Re-irradiation of High Grade Gliomas: a Quality of Life Study
NCT01711580 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-05-12
Summary
Patients with a high grade glioma have an increasing overall survival and progression free survival after initial treatment. Because of a better performance status these patients are more often eligible for re-treatment with for example radiotherapy. However, to date only a few prospective studies on re-irradiation of gliomas exist and very little is known about the effects of re-irradiation on quality of life and cognition. This trial is designed to longitudinally establish the effects of re-irradiation on quality of life, cognition and physical performance in patients with a high grade glioma. Based on the currently available information the investigators hypothesize that quality of life after re-irradiation can be kept stable until further tumour progression.
Conditions
- Anaplastic Astrocytoma
- Glioblastoma Multiforme
- Anaplastic Oligoastrocytoma
Interventions
- OTHER
-
EORTC QLQ-C30
The EORTC QLQ-C30 is a questionnaire developed to assess the quality of life of cancer patients. It is supplemented by disease specific modules for e.g. Breast, Lung, Head \& Neck, Oesophageal, Ovarian, Gastric, Cervical cancer, Multiple Myeloma, Oesophago-Gastric, Prostate, Colorectal Liver Metastases, Colorectal and Brain cancer which are distributed from the EORTC Quality of Life Department. Other disease specific modules are under development but not yet validated.
- OTHER
-
EORTC QLQ-BN20
The EORTC QLQ-C30 is a questionnaire developed to assess the quality of life of cancer patients. It is supplemented by disease specific modules for e.g. Breast, Lung, Head \& Neck, Oesophageal, Ovarian, Gastric, Cervical cancer, Multiple Myeloma, Oesophago-Gastric, Prostate, Colorectal Liver Metastases, Colorectal and Brain cancer which are distributed from the EORTC Quality of Life Department. Other disease specific modules are under development but not yet validated.
- OTHER
-
Hopkins Verbal Learning Test-Revised (HVLT-R)
The HVLT-R is a cognitive test to assess verbal learning and memory.
- OTHER
-
Stroop color-word test
The Stroop Color and Word Test is a brief five minute test which is used to assess brain dysfunction, cognition, and psychopathology.
- OTHER
-
Controlled oral word association test (COWA)
The COWA is a measure of verbal fluency that requires expressive language and executive functions.
- OTHER
-
Jamar hand dynamometer
The Jamar hand dynamometer is a screening instrument that is used to assess grip strength.
- OTHER
-
EORTC QLQ- FA13
The Fatigue Questionnaire (QLQ-FA13) is a 13-item questionnaire to assess fatigue in patients with cancer. It is meant to be used in conjunction with the EORTC QLQ-C30
- OTHER
-
Trail Making Test (TMT)
The TMT The Trail Making Test is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as fast as possible while still maintaining accuracy.
Sponsors & Collaborators
-
Maastricht Radiation Oncology
lead OTHER
Principal Investigators
-
Brigitta Baumert, MD, MBA · Maastro Clinic, The Netherlands
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-09-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NCT06215495 ·Status: RECRUITING ·Phase: NA
-
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
NCT04771806 ·Status: RECRUITING
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Image Guided Reirradiation of High-grade Glioma
NCT02025231 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Non-invasive Glioma Characterization Through Molecular Imaging
NCT03684109 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
NCT01018329 ·Status: COMPLETED ·Phase: NA
-
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
NCT01305122 ·Status: TERMINATED ·Phase: NA
-
Post-operative Imaging in High Grade Glioma: is Management Influenced?
NCT04738110 ·Status: UNKNOWN
-
Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers
NCT01638130 ·Status: RECRUITING
-
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
NCT02540135 ·Status: WITHDRAWN ·Phase: NA
-
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
NCT06381726 ·Status: RECRUITING ·Phase: NA
-
Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas
NCT06454097 ·Status: RECRUITING ·Phase: NA
-
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
NCT03294434 ·Status: COMPLETED
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NCT04699773 ·Status: RECRUITING ·Phase: NA
-
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
NCT05970757 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
NCT06183983 ·Status: RECRUITING ·Phase: NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
NCT04181684 ·Status: RECRUITING ·Phase: NA
-
Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma
NCT05964569 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
NCT01011231 ·Status: TERMINATED ·Phase: PHASE2
-
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
NCT00250211 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
NCT03903419 ·Status: UNKNOWN ·Phase: NA
-
qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.
NCT02466828 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Immunophenotyping From Blood of Patients With Malignant Gliomas
NCT02022384 ·Status: COMPLETED
-
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
NCT00870129 ·Status: RECRUITING ·Phase: NA